Communiqués Bora Pharmaceuticals Co., LTD.

Actions

6472

TW0006472004

Cours en clôture Taiwan S.E. Autres places de cotation 00:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
764 ^TWD	+4,66%		+1,60%	+19,56%

14/05	Bora Pharmaceuticals Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
01/04	Bora Pharmaceuticals Co. (TWSE:6472) a finalisé l'acquisition de Sawai America Holdings Inc. auprès de Sawai Group Holdings Co, Ltd. (TSE:4887).	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Bora Pharmaceuticals : The Company's Board of Director's resolution on the execution of syndicated loan	12/08/22	PU
Bora Pharmaceuticals : The Board of Director's resolution on not distributing dividend for first half of 2022	12/08/22	PU
Bora Pharmaceuticals : The Company's Board of Director's resolution on ex-rights date	12/08/22	PU
Bora Pharmaceuticals : The Company's Board of Director's resolution on the Company's 2022 Q2 financial statement	12/08/22	PU
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date(additional information)	27/06/22	PU
Bora Pharmaceuticals : Announcement on the Company's resolution on cash dividend date	22/06/22	PU
Bora Pharmaceuticals : The Company's stock has reached the announcement criteria several times recently. The below information is published for investor's information	22/06/22	PU
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash dividend date	21/06/22	PU
Bora Pharmaceuticals : To announce the Company to acquire 100% common share of TWi Pharmaceuticals, Inc.	14/06/22	PU
Bora Pharmaceuticals : The Company's Board of Directors passes the reolution to increase cash capital for the subsidiary	14/06/22	PU
Bora Pharmaceuticals : The Company's Board of Director's resolution on convening 2022 1st extraordinary stockholder meeting	14/06/22	PU
Bora Pharmaceuticals : To announce the press release for the Company's press conference on material information today	14/06/22	PU
Bora Pharmaceuticals : The Company's Board of Director's resolution on issung 2nd domestic unsecured convertible corporate bonds	14/06/22	PU
Bora Pharmaceuticals : To announcement the Company to hold a material information press conference on June 14, 2022	14/06/22	PU
Bora Pharmaceuticals : The Company's shareholder's resolution to discharge the director's non-compete clause	24/05/22	PU
Bora Pharmaceuticals : Announce on the Company's resolution for 2021 annual general shareholders' meeting	24/05/22	PU
Bora Pharmaceuticals : Announcement on behalf of the material subsidiary, Bora Bora Pharmaceutical Laboratories Inc., for the Board resolution on cash capital increase	11/04/22	PU
Bora Pharmaceuticals : To announce in accordance with Article 25.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies	11/04/22	PU
Bora Pharmaceuticals : The Company's announcement to the creditor due to the spin off	11/04/22	PU
Bora Pharmaceuticals : The Company's Board of Director's resolution on the spin off	11/04/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Bora Pharmaceuticals Co., LTD.

Actions

6472

TW0006472004

Communiqués

Filtres